Current Report Filing (8-k)
07 January 2017 - 8:32AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 6, 2017
Minerva Neurosciences, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-36517
|
|
26-0784194
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
1601 Trapelo Road
Suite 284
Waltham,
MA
|
|
02451
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(Registrants telephone number, including area code): (617)
600-7373
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to
Rule 14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to
Rule 14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to
Rule 13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Minerva Neurosciences, Inc. (the Company) is filing the
investor presentation slides attached as Exhibit 99.1 to this Current Report on Form
8-K
which the Company may use from time to time in conversations with investors and analysts. The presentation will also be
available on the investor relations section of the Companys website.
Item 9.01.
|
Financial Statements and Exhibits.
|
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.1
|
|
Investor Presentation dated January 2017.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
MINERVA NEUROSCIENCES, INC.
|
|
|
By:
|
|
/s/ Mark S. Levine
|
Name:
|
|
Mark S. Levine
|
Title:
|
|
Senior Vice President, General Counsel and Secretary
|
Date: January 6, 2017
INDEX OF EXHIBITS
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.1
|
|
Investor Presentation dated January 2017.
|
Minerva Neurosciences (NASDAQ:NERV)
Historical Stock Chart
From Apr 2024 to May 2024
Minerva Neurosciences (NASDAQ:NERV)
Historical Stock Chart
From May 2023 to May 2024